logo
Select company
Select metric
0.76Cash Ratio
VS
Market
61
Sector
35
Industry
21
History
3
$ 10.13Close
$ 5.54 - $ 18.57 52-Week Range
Ticker Information

Ticker

KURA

Company Name

KURA ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KURA ONCOLOGY INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KURA - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 81.95M0.76$ 107.17M
3/31/2025$ 51.27M0.57$ 89.77M
12/31/2024$ 224.46M2.85$ 78.71M
9/30/2024$ 49.48M1.23$ 40.37M
6/30/2024$ 45.18M1.35$ 33.45M
3/31/2024$ 41.51M1.29$ 32.27M
12/31/2023$ 37.32M1.06$ 35.26M
9/30/2023$ 28.74M1.04$ 27.52M
6/30/2023$ 49.33M2.06$ 23.9M
3/31/2023$ 27.27M1.42$ 19.23M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KURA ONCOLOGY INC's latest trailing twelve months (TTM) Cash Ratio stands at 3.56.
  • Over the past 5 years, KURA ONCOLOGY INC's average Cash Ratio has been 2.59.
  • The median Cash Ratio for KURA ONCOLOGY INC during this period was 1.88
  • KURA ONCOLOGY INC reached its highest Cash Ratio over the past 5 years at 12.52.
  • The lowest Cash Ratio recorded by KURA ONCOLOGY INC in the same timeframe 0.57

KURA ONCOLOGY INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
SAGE : SAGE THERAPEUTICS INC 1.54NKTR : NEKTAR THERAPEUTICS 0.6YMAB : Y-MABS THERAPEUTICS INC 2.71TBPH : THERAVANCE BIOPHARMA INC 5.18ADCT : ADC THERAPEUTICS SA 4.1LXRX : LEXICON PHARMACEUTICALS INC 1.45ZVRA : ZEVRA THERAPEUTICS INC 1.65GYRE : GYRE THERAPEUTICS INC 2.16GOSS : GOSSAMER BIO INC 0.49TRDA : ENTRADA THERAPEUTICS INC 3.86

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for KURA ONCOLOGY INC is calculated as follows: CashnEq [ $ 77.17M ] / LiabilitesC [ $ 21.7M ]
(=) Cash Ratio [ 3.56 ]

KURA - Cash Ratio, Last 5 years

0.57

Minimum

Mar 31, 2025

12.52

Maximum

Dec 31, 2020

2.59

Average

1.88

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63